Abstract:Changxiu Ma, 1 Ying Zhang, 1 Tingchao Tian, 2 Ling Zheng, 1 Jing Ye, 1 Hui Liu, 1 Dahai Zhao 1 1 Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Anhui Medical University, Hefei, 230601, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Huoqiu First People's Hospital, Huoqiu, 237400, People's Republic of China Correspondence: Dahai Zhao, Second Affiliated Hospital, Anhui Medical University, 678 Furong Road, Hefei, Anhui Province, 230601, People's Republic of China, Tel +86-13721027959, Email Purpose: To explore the role of the mean apnea–hypopnea duration (MAD) and apnea–hypopnea duration per hour (HAD) in hypoxemia and evaluate whether they can effectively predict the occurrence of hypoxemia among adults with OSA. Patients and Methods: A total of 144 participants underwent basic information gathering and polysomnography (PSG). Logistic regression models were conducted to evaluate the best index in terms of hypoxemia. To construct the prediction model for hypoxemia, we randomly divided the participants into the training set (70%) and the validation set (30%). Results: The participants with hypoxemia tend to have higher levels of obesity, diabetes, AHI, MAD, and HAD compared with non-hypoxemia. The most relevant indicator of blood oxygen concentration is HAD (r = 0.73) among HAD, MAD, and apnea–hypopnea index (AHI). The fitness of HAD on hypoxemia showed the best. In the stage of establishing the prediction model, the area under the curve (AUC) values of both the training set and the validation set are 0.95. The increased HAD would elevate the risk of hypoxemia [odds ratio (OR): 1.30, 95% confidence interval (CI): 1.13– 1.49]. Conclusion: The potential role of HAD in predicting hypoxemia underscores the significance of leveraging comprehensive measures of respiratory disturbances during sleep to enhance the clinical management and prognostication of individuals with sleep-related breathing disorders. Keywords: mean apnea–hypopnea duration, obstructive sleep apnea, apnea–hypopnea duration per hour, polysomnography, apnea–hypopnea index Hypoxemia, characterized by an inadequate level of oxygen in the arterial blood, represents a significant physiological disturbance with far-reaching implications for individual health. 1 Inadequate tissue oxygenation can result in the occurrence and development of various diseases, such as cognitive impairment, 2 cardiac impairment, 3,4 pulmonary hypertension, 5 and compromised immune function, 6 thereby increasing the risk of morbidity and mortality. It is noteworthy that hypoxemia is now being recognized as a potentially major factor contributing to the pathogenesis of obstructive sleep apnea (OSA)-related comorbidities. 7 Furthermore, the hypoxemia associated with OSA is gaining recognition as a significant factor that fosters the development and progression of cancer. 8 Therefore, early identification and intervention for hypoxemia is imperative in mitigating its adverse effects and preventing the occurrence of severe comorbidities, especially for patients with OSA. The Apnea–Hypopnea Index (AHI) serves as a crucial metric in the assessment of sleep-disordered breathing, encompassing both apneas (complete cessation of airflow) and hypopneas (partial airflow reduction) during sleep. AHI has been widely utilized as a diagnostic tool to quantify the severity of OSA. 9 However, as a diagnostic criterion, the AHI reflects only a portion of the pathophysiological characteristics of OSA, 10,11 it cannot reflect the degrees of hypoxemia and sleep fragmentation or the duration and distribution of respiratory events. 12,13 Furthermore, AHI's reliance on quantifying respiratory events without direct consideration of oxygen saturation dynamics, intermittent hypoxemia, or related physiological responses presents a notable drawback in the comprehensive assessment of sleep-related hypoxemia. This insufficiency underscores the need for complementary metrics and assessment tools to more accurately predict and evaluate the risk of hypoxemia during sleep, thereby enhancing the clinical management and prognostication of individuals with sleep-disordered breathing. With the gradual prolongation of apnea and hypopnea event durations, oxygen reserves are gradually depleted, causing a series of effects on the body, such as sleep fragmentation, cardiac dysfunction, hypertension, endothelial impairment, atrial fibrillation, and even sudden cardiac death. 7,14–16 These suggested that the duration of adverse respiratory events may be closely related to -Abstract Truncated-

Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population

Evaluating the clinical value of the hypoxia burden index in patients with obstructive sleep apnea.

The effectiveness of sleep breathing impairment index in assessing obstructive sleep apnea severity.

The use of the sleep apnea-specific hypoxic burden to predict obstructive sleep apnea hypopnea syndrome: Evidence from a large cross-sectional study

Linear Relationship between Hepatic Steatosis Index and Major Adverse Cardiovascular Events in Hypertensive Patients with Obstructive Sleep Apnea: A Real-World Cohort Study from China

Sustained oximetric desaturation as a cardiac risk indicator remains correlated with nonspecific sleep apnea indices.

Interrelationships among Common Predictors of Cardiovascular Diseases in Patients of OSA: A Large-Scale Observational Study.

Feasibility of screening and diagnosing obstructive sleep apnea-hypopnea syndrome by oxygen desaturation index and its association with nighttime blood pressure

The prognostic capacity of Sleep apnea-specific hypoxic burden on the incidence of cardiovascular events: A comparative study with tradicional polygraphic parameters in patients with Obstructive Sleep Apnea.

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Assessing the contribution of mild high-altitude exposure to obstructive sleep apnea-hypopnea syndrome comorbidities

Diagnostic Accuracy of Oxygen Desaturation Index for Sleep-Disordered Breathing in Patients with Diabetes

The Diagnosis Value of the Combination of Oxygen Desaturation Index and Epworth Sleepiness Scale in Obstructive Sleep Apnea-Hypopnea Syndrome

Diagnostic accuracy of a questionnaire and simple home monitoring device in detecting obstructive sleep apnoea in a Chinese population at high cardiovascular risk: Simplified ambulatory diagnosis of OSA

Evaluating the Clinical Value of Oscillatory Cardiopulmonary Coupling in Patients with Obstructive Sleep Apnea Hypopnea Syndrome by Impedance Cardiogram

Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma (AIP) and apoB/apoAI ratio

Using Apnea–Hypopnea Duration per Hour to Predict Hypoxemia Among Patients with Obstructive Sleep Apnea

Multimodal data integration for enhanced longitudinal prediction for cardiac and cerebrovascular events following initial diagnosis of obstructive sleep apnea syndrome

Relationship Between Monocyte to HDL Cholesterol Ratio and Concomitant Cardiovascular Disease in Chinese Han Patients with Obstructive Sleep Apnea.

Long-term mortality risk in obstructive sleep apnea: the critical role of oxygen desaturation index

Blood Oxygen Accumulation Distribution Area Index is Associated with Erectile Dysfunction in Patients with Sleep Apnea-Results from a Cross-sectional Study.